BARCONA Trial: A Randomized Trial of Bardoxolone Methyl in Patients Infected with SARS-Corona Virus-2 (COVID-19)

Brief description of study

The purpose of this research study is to find out if bardoxolone methyl is safe to use for people with COVID-19 and if it will help increase the odds of recovery for people with COVID-19. Bardoxolone methyl is considered an investigational drug because it is not approved by the Food and Drug Administration (FDA) to treat COVID-19. This research study will compare bardoxolone methyl to a placebo. A placebo is used in research studies to compare the results and side effects of the drug being studied to the results and side effects of taking no medication.


Clinical Study Identifier: s20-00591
ClinicalTrials.gov Identifier: NCT04494646


If you are registered as a volunteer, please login to the dashboard to send referrals.